Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.
Send us all your questions or requests, and our expert team will assist you.
Peyronie’s disease is a connective tissue disorder where fibrous plaques form in the tunica albuginea of the penis. This happens when the body’s normal healing response to small blood vessel injuries goes off track. The tunica albuginea is made of collagen and elastin fibers, which give the penis its structure and help it function during an erection. In this disease, too much collagen builds up and elastin decreases, making the tissue less elastic. As a result, plaques form, leading to changes in shape like curvature, dents, or shortening.
The way we define Peyronie’s disease has changed from focusing only on anatomy to understanding the molecular processes behind scarring. The disease develops when inactive fibroblast cells turn into active myofibroblasts, mainly because of high levels of certain signaling proteins like Transforming Growth Factor beta 1. This protein triggers a pathway that increases the production of genes that cause scarring. As a result, the tunica albuginea changes from being flexible to becoming stiff and scarred. The plaque is not just a simple scar—it is active tissue that can go through stages of inflammation, hardening, and even bone-like changes.
Looking at it from a regenerative medicine point of view, Peyronie’s disease is a problem with how the body breaks down and rebuilds the tissue around cells. Normally, enzymes called matrix metalloproteinases break down collagen, but in this disease, their action is blocked, so scar tissue builds up. Experts now also see Peyronie’s as part of a broader pattern, since it is linked to other conditions like Dupuytren’s contracture. This means some people may have a genetic or metabolic tendency to develop scarring, and Peyronie’s disease is one way this shows up.
To understand Peyronie’s disease today, it helps to look at the molecular signals in the tissue. The process often starts with a small, unnoticed injury during sexual activity, which causes blood proteins to leak out and form a clot. In people who are prone to the disease, this clot attracts inflammatory cells. These cells then release various signaling proteins, such as Platelet Derived Growth Factor, basic Fibroblast Growth Factor, and especially TGF beta 1.
Reactive oxygen species, or harmful molecules produced during stress, are also important in Peyronie’s disease. When these build up in the tunica albuginea, they make inflammation worse and damage cell membranes. This environment keeps the scar-forming cells active, leading to ongoing scarring. Because these signals don’t turn off, the tissue stays stuck in a state of constant repair and scarring.
Another factor in Peyronie’s disease is a problem with the nitric oxide pathway. Nitric oxide normally helps prevent scarring and removes harmful molecules. In this disease, the body makes less nitric oxide, so there is less protection against scar tissue forming. Without this natural control, scarring can continue without being stopped.
Worldwide, treatment for scarring conditions like Peyronie’s disease is moving toward targeted therapies and regenerative medicine. Instead of relying only on surgery, doctors are now using treatments that change how the plaque develops. New drugs are being developed to block the TGF beta 1 pathway or to help enzymes break down excess collagen.
Researchers are also studying stem cell treatments, especially those using cells from body fat. These stem cells release substances that help control the immune system, lower inflammation, and reduce scarring. New clinical approaches use patient data to decide when to start treatment, making sure therapies are given when they are most likely to work.
The main problem area in Peyronie’s disease is the extracellular matrix of the tunica albuginea. Normally, this area has well-organized collagen fibers that let the penis expand during an erection. In the disease, these fibers become disorganized, which changes how the tissue works and causes the penis to curve. The matrix also traps inflammatory proteins, which keeps the plaque active for longer.
Regenerative treatments focus on changing this matrix. For example, injecting collagenase directly into the plaque breaks down the collagen fibers, weakening the plaque. This process acts like a targeted, non-surgical treatment and helps the tissue become more flexible. Afterward, stretching therapies can further remodel the tissue.
Energy-based treatments are changing how doctors manage Peyronie’s disease without surgery. Low-intensity shockwave therapy uses sound waves to send signals into the tissue. These signals help new blood vessels grow, lower inflammation, and may help break up hard plaques. This approach offers a way to treat scarring without the risks of surgery.
Send us all your questions or requests, and our expert team will assist you.
An ongoing inflammatory process characterizes the acute or active phase. Patients often experience pain with or without an erection, and the curvature or deformity of the penis may be changing or worsening. Biologically, this phase involves active cell turnover and elevated inflammatory signaling. The chronic or stable phase is defined by the resolution of pain and the stabilization of the curvature for at least three months. In this phase, inflammation has subsided, and the plaque consists of dense, stable scar tissue or calcified tissue.
No, Peyronie’s disease is strictly a benign, non-cancerous condition. It involves the formation of fibrous scar tissue, similar to a keloid on the skin, but located within the internal sheath of the penis. Although the plaque can feel hard like a tumor, it does not possess the cellular characteristics of malignancy, does not metastasize, and does not increase the risk of developing penile cancer.
Spontaneous resolution of the plaque and complete disappearance of the curvature are rare. While the pain associated with the acute phase typically resolves over time as the inflammation subsides, the structural deformity usually persists or stabilizes. Without medical or surgical intervention, the fibrous tissue remains integrated into the tunica albuginea.
Diabetes mellitus is a significant risk factor for more severe disease and poorer healing. High blood sugar levels lead to the glycation of proteins, including collagen, making the tissue more rigid and resistant to natural remodeling. Diabetes also impairs the microvascular blood supply, reducing the delivery of oxygen and immune cells needed to regulate the healing process, thereby promoting denser fibrosis.
Immunosuppressive Therapy is not a quick fix. It typically takes 3 to 6 months to see a meaningful improvement in blood counts. Patience is key. During this time, the patient remains dependent on transfusions and careful infection prevention.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
